Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells

被引:26
|
作者
Niemann, B
Rohrbach, S
Catar, RA
Muller, G
Barton, M
Morawietz, H
机构
[1] Tech Univ Dresden, Fac Med, Dept Vasc Endothelium & Microcirculat, D-01307 Dresden, Germany
[2] Univ Halle Wittenberg, Inst Pathophysiol, D-06097 Halle Saale, Germany
[3] Univ Zurich Hosp, Dept Med, Med Policlin, CH-8091 Zurich, Switzerland
关键词
atherosclerosis; endothelin-1; endothelia-converting enzyme-1; endothelium; low-density lipoprotein; prepro-endothelia-1;
D O I
10.1016/j.bbrc.2005.06.163
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
This study addressed the question how different lipoproteins modulate the expression of endothelia-converting enzyme-1 (ECE-1) in human endothelial cells. The effect of native and oxidized low-density lipoproteins (nLDL, oxLDL) on expression of ECE-1, prepro-endothelin-1, and endothelin-1 peptide was studied in primary cultures of human endothelial cells. Native and oxidized LDL increased ECE-1 mRNA after 1 h, reaching its maximum at 100 mu g/ml (1.9- and 2.5-fold, respectively). Furthermore, ECE-1 protein expression, prepro-endothelin-1 mRNA, and endothelin-1 peptide release were increased in response to nLDL or oxLDL. Induction of ECE-1 by nLDL and of prepro-endothelin-1 by oxLDL was reduced by protein kinase C inhibition. Increased expression of ECE-1 mRNA by oxLDL and of prepro-endothelin-1 by nLDL was blocked by an angiotensin 11 receptor type 1 antagonist. Our data provide evidence for a new mechanists how increased LDL plasma levels might contribute to enhanced endothelin-1 release in patients with hypercholesterolemia. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:747 / 753
页数:7
相关论文
共 50 条
  • [41] Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis
    Minamino, T
    Kurihara, H
    Takahashi, M
    Shimada, K
    Maemura, K
    Oda, H
    Ishikawa, T
    Uchiyama, T
    Tanzawa, K
    Yazaki, Y
    CIRCULATION, 1997, 95 (01) : 221 - 230
  • [42] Alterations of endothelin-converting enzyme expression in early and advanced stages of human coronary atherosclerosis
    Hai, E
    Ikura, Y
    Naruko, T
    Shirai, N
    Yoshimi, N
    Kayo, S
    Sugama, Y
    Fujino, H
    Ohsawa, M
    Tanzawa, K
    Yokota, T
    Ueda, M
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2004, 13 (05) : 649 - 654
  • [43] Human endothelial cell storage granules - A novel intracellular site for isoforms of the endothelin-converting enzyme
    Russell, FD
    Skepper, JN
    Davenport, AP
    CIRCULATION RESEARCH, 1998, 83 (03) : 314 - 321
  • [44] Ligand-based drug design for human endothelin converting enzyme-1 inhibitors
    Karunakar Tanneeru
    Itishri Sahu
    Lalitha Guruprasad
    Medicinal Chemistry Research, 2013, 22 : 4401 - 4409
  • [45] RECEPTORS FOR MODIFIED LOW-DENSITY LIPOPROTEINS ON HUMAN ENDOTHELIAL-CELLS - DIFFERENT RECOGNITION FOR ACETYLATED LOW-DENSITY-LIPOPROTEIN AND OXIDIZED LOW-DENSITY-LIPOPROTEIN
    KUME, N
    ARAI, H
    KAWAI, C
    KITA, T
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1091 (01) : 63 - 67
  • [46] Low-density lipoproteins induce the polar secretion of PAI-1 by endothelial cells in culture
    Jovin, IS
    Willuweit, A
    Taborski, U
    Lehnhardt, A
    Schreiner, K
    Klövekorn, WP
    Müller-Berghaus, G
    AMERICAN JOURNAL OF HEMATOLOGY, 2003, 73 (01) : 66 - 68
  • [47] The Role of NOX2-Derived Reactive Oxygen Species in the Induction of Endothelin-Converting Enzyme-1 by Angiotensin II
    Adu-Gyamfi, Michael
    Goettsch, Claudia
    Kamhieh-Milz, Julian
    Chen, Lei
    Pfefferkorn, Anna Maria
    Hofmann, Anja
    Brunssen, Coy
    Mueller, Gregor
    Walther, Thomas
    Ashraf, Muhammad Imtiaz
    Morawietz, Henning
    Witowski, Janusz
    Catar, Rusan
    ANTIOXIDANTS, 2024, 13 (04)
  • [48] Ligand-based drug design for human endothelin converting enzyme-1 inhibitors
    Tanneeru, Karunakar
    Sahu, Itishri
    Guruprasad, Lalitha
    MEDICINAL CHEMISTRY RESEARCH, 2013, 22 (09) : 4401 - 4409
  • [49] Attenuation of Doxorubicin-Induced Cardiomyopathy by Endothelin-Converting Enzyme-1 Ablation Through Prevention of Mitochondrial Biogenesis Impairment
    Miyagawa, Kazuya
    Emoto, Noriaki
    Widyantoro, Bambang
    Nakayama, Kazuhiko
    Yagi, Keiko
    Rikitake, Yoshiyuki
    Suzuki, Takashi
    Hirata, Ken-ichi
    HYPERTENSION, 2010, 55 (03) : 738 - U67
  • [50] Influence of oxidized low-density lipoproteins (LDL) on the viability of osteoblastic cells
    Brodeur, Mathieu R.
    Brissette, Louise
    Falstrault, Louise
    Ouellet, Pascale
    Moreau, Robert
    FREE RADICAL BIOLOGY AND MEDICINE, 2008, 44 (04) : 506 - 517